Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

Similar articles for PubMed (Select 16118381)

1.

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.

JAMA. 2005 Aug 24;294(8):914-23.

2.

A prospective study of aspirin use and the risk for colorectal adenoma.

Chan AT, Giovannucci EL, Schernhammer ES, Colditz GA, Hunter DJ, Willett WC, Fuchs CS.

Ann Intern Med. 2004 Feb 3;140(3):157-66.

PMID:
14757613
3.

Aspirin dose and duration of use and risk of colorectal cancer in men.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS.

Gastroenterology. 2008 Jan;134(1):21-8. Epub 2007 Sep 26.

4.

Long-term use of aspirin and the risk of gastrointestinal bleeding.

Huang ES, Strate LL, Ho WW, Lee SS, Chan AT.

Am J Med. 2011 May;124(5):426-33. doi: 10.1016/j.amjmed.2010.12.022.

5.

Aspirin and the risk of colorectal cancer in women.

Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE.

N Engl J Med. 1995 Sep 7;333(10):609-14.

6.

A prospective study of aspirin use and the risk of pancreatic cancer in women.

Schernhammer ES, Kang JH, Chan AT, Michaud DS, Skinner HG, Giovannucci E, Colditz GA, Fuchs CS.

J Natl Cancer Inst. 2004 Jan 7;96(1):22-8.

7.

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.

García-Rodríguez LA, Huerta-Alvarez C.

Epidemiology. 2001 Jan;12(1):88-93.

PMID:
11138826
8.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

9.

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.

Grau MV, Sandler RS, McKeown-Eyssen G, Bresalier RS, Haile RW, Barry EL, Ahnen DJ, Gui J, Summers RW, Baron JA.

J Natl Cancer Inst. 2009 Feb 18;101(4):267-76. doi: 10.1093/jnci/djn484. Epub 2009 Feb 10.

10.

Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.

Peleg II, Maibach HT, Brown SH, Wilcox CM.

Arch Intern Med. 1994 Feb 28;154(4):394-9.

PMID:
8117171
11.

Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.

Johnson TW, Anderson KE, Lazovich D, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1586-91.

13.

Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study.

Smalley W, Ray WA, Daugherty J, Griffin MR.

Arch Intern Med. 1999 Jan 25;159(2):161-6.

PMID:
9927099
14.

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.

Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.

J Natl Cancer Inst. 2005 Jun 1;97(11):805-12.

15.

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.

Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ.

J Natl Cancer Inst. 2005 Jul 6;97(13):975-80.

16.

Prospective study of regular aspirin use and the risk of breast cancer.

Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA.

J Natl Cancer Inst. 1996 Jul 17;88(14):988-93.

17.

Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.

Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A; Women's Health Initiative.

Cancer Res. 2003 Sep 15;63(18):6096-101.

18.

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

Flossmann E, Rothwell PM; British Doctors Aspirin Trial and the UK-TIA Aspirin Trial.

Lancet. 2007 May 12;369(9573):1603-13. Review.

PMID:
17499602
19.

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, Grove A, Gurung B, Morrow S, Clarke A.

Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Review.

20.

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE.

Arch Intern Med. 2009 Jan 26;169(2):115-21; discussion 121. doi: 10.1001/archinternmed.2008.537.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk